Fundz

Tyra Biosciences Appoints Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer

PUBLIC · TYRADec 01, 2025

Position

Chief Regulatory Officer

Company

Tyra Biosciences

Heather Faulds
CarlsbadBiotechnologyHealth CareTherapeutics

Description

Tyra Biosciences announced the appointment of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer. Ashar's appointment is effective immediately, while Faulds's will commence on December 8, 2025.

Quick answer

Tyra Biosciences Appoints Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer (December 1, 2025). Tyra Biosciences is based in Carlsbad, California, United States.

Who is the new Chief Regulatory Officer at Tyra Biosciences?
Tyra Biosciences named Heather Faulds Chief Regulatory Officer, announced December 1, 2025.
What did Tyra Biosciences announce on December 1, 2025?
Tyra Biosciences announced the appointment of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer. Ashar's appointment is effective immediately, while Faulds's will commence on December 8, 2025.
What does Tyra Biosciences do?
Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology.
Where is Tyra Biosciences based?
Tyra Biosciences is based in Carlsbad, California, United States.
Which similar companies made leadership changes around the same time?
Whitehawk Therapeutics, Inc. (December 1, 2025), VistaGen (December 1, 2025), Novocure (December 1, 2025) and Jubilant Therapeutics (December 2, 2025) also announced leadership changes within 45 days of Tyra Biosciences.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Tyra Biosciences, and when

A new leader at Tyra Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Tyra Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tyra Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tyra Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tyra Biosciences

Location

2656 State Street

Carlsbad, California, United States

About

Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tyra Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Todd
Likely contact at this company
••••••••@••••••••

See Todd's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Tyra Biosciences's next move

Learn about Strategic plan

Tyra Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.